Generic Name: pazopanib
Common side effects of Votrient include: hemorrhagic diathesis, abdominal pain, decreased serum glucose, decreased serum magnesium, decreased serum phosphate, diarrhea, fatigue, hypertension, increased serum alanine aminotransferase, increased serum aspartate aminotransferase, increased serum bilirubin, leukopenia, nausea, neutropenia, thrombocytopenia, vomiting, and anorexia. Other side effects include: hypothyroidism, and proteinuria.  See below for a comprehensive list of adverse effects.
Applies to pazopanib: oral tablet
As well as its needed effects, pazopanib (the active ingredient contained in Votrient) may cause unwanted side effects that require medical attention. 
If any of the following side effects occur while taking pazopanib, check with your doctor immediately:
Some pazopanib side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:


Applies to pazopanib: oral tablet
-ALT and AST elevations occurred early in the treatment course; 92.5% of all transaminase elevations of any grade occurred in the first 18 weeks.-Hepatic failure was the cause of death for 0.2% of RCC patients and 0.4% of STS patients.[Ref]
Very common (10% or more): Increased ALT (up to 53%), increased AST (up to 53%), increased total bilirubin (up to 36%), increased alkaline phosphatase (up to 32%)Common (1% to 10%): Abnormal hepatic function, hepatotoxicity, decreased alkaline phosphatase, increased gamma-glutamyltransferase (GGT), abnormal liver function test Uncommon (0.1% to 1%): Jaundice, drug-induced liver injury, hepatic failure, increased hepatic enzymePostmarketing reports: Increased GGT[Ref]
-A majority of the patients with myocardial dysfunction had concurrent hypertension which may have exacerbated cardiac dysfunction in patients at risk possibly by increasing cardiac afterload.-Cardiac dysfunction included left ventricular dysfunction, cardiac failure, and restrictive cardiomyopathy.-Venous thromboembolic events included deep vein thrombosis, pulmonary embolism, and thrombosis terms.[Ref]
Very common (10% or more): Hypertension (up to 42%), myocardial dysfunction (up to 11%), chest pain (up to 10%)Common (1% to 10%): Venous thromboembolic events, cardiac dysfunction, bradycardia, QT prolongation, myocardial infarction or ischemia, hot flush, flushingUncommon (0.1% to 1%): Torsades de pointes, congestive heart failure, fatal arterial thromboembolic events, hypertensive crisis[Ref]
Very common (10% or more): Tumor pain (up to 32%), hemorrhagic events (up to 13%)Common (1% to 10%): Edema, epistaxis, mouth ulceration, dry mouth, mucosal inflammation, gingival infection, hiccupsUncommon (0.1% to 1%): Fatal hemorrhage, cerebral/intracranial hemorrhage, infections (with or without neutropenia), infectious peritonitis, menorrhagia, metrorrhagia, oropharyngeal painPostmarketing reports: Infections (with or without neutropenia)[Ref]
-RCC: The most common hemorrhagic events were hematuria, epistaxis, hemoptysis, and rectal hemorrhage.-STS: The most common hemorrhagic events were epistaxis, mouth hemorrhage, and anal hemorrhage.-Edema events included peripheral edema, eye edema, localized edema, and face edema.[Ref]
-TMA included thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS).[Ref]
Very common (10% or more): Increased creatinine (up to 26%), proteinuria (up to 12%)Common (1% to 10%): Increased ureaUncommon (0.1% to 1%): Nephrotic syndrome, thrombotic microangiopathy (TMA)Postmarketing reports: Thrombotic microangiopathy (TMA)[Ref]
Very common (10% or more): Diarrhea (up to 59%), nausea (up to 56%), vomiting (up to 33%), gastrointestinal pain (up to 23%), abdominal pain (up to 14%), mucositis (up to 12%), stomatitis (up to 11%)Common (1% to 10%): Dyspepsia, flatulence, abdominal distensionUncommon (0.1% to 1%): Perforation or fistula, fatal perforations, hematochezia, melena, frequent bowel movements, hematemesis, pancreatitis, peritonitisPostmarketing reports: Pancreatitis, flatulence[Ref]
Very common (10% or more): Fatigue (up to 65%), dysgeusia (up to 28%), headache (up to 23%), dizziness (up to 11%)Common (1% to 10%): Insomnia, dysphonia, lethargy, paresthesia, peripheral sensory neuropathy, chillsUncommon (0.1% to 1%): Hypoesthesia, somnolence, mucous membrane disorder, cerebral infarction, transient ischemic attack, cerebrovascular accident, ischemic stroke, posterior reversible encephalopathy syndrome/reversible posterior leukoencephalopathy syndrome (PRES/RPLS)Postmarketing reports: PRES/RPLS[Ref]
-Dysgeusia included ageusia and hypogeusia.[Ref]
Common (1% to 10%): Hypothyroidism, increased thyroid stimulating hormoneUncommon (0.1% to 1%): Abnormal thyroid function test[Ref]
-Renal cell carcinoma (RCC): The most commonly observed adverse reactions (20% or more) were diarrhea, hypertension, hair color change, nausea, fatigue, anorexia, and vomiting.-Soft tissue sarcoma (STS): The most commonly observed adverse reactions (20% or more) were fatigue, diarrhea, nausea, decreased weight, hypertension, decreased appetite, vomiting, tumor pain, hair color changes, musculoskeletal pain, headache, dysgeusia, dyspnea, and skin hypopigmentation.[Ref]
Very common (10% or more): Hair color changes (up to 39%), skin hypopigmentation (up to 21%), exfoliative rash (up to 18%), palmar-plantar erythrodysesthesia syndrome (up to 18%), alopecia (up to 12%), rash (up to 11%)Common (1% to 10%): Dry skin, skin depigmentation, nail disorder, pruritus, erythema, hyperhidrosisUncommon (0.1% to 1%): Skin exfoliation, photosensitivity reaction, erythematous rash, skin disorder, macular rash, pruritic rash, vesicular rash, papular rash, skin ulcer[Ref]
Common (1% to 10%): Hematuria[Ref]
Very common (10% or more): Leukopenia (up to 44%), lymphocytopenia (up to 43%), thrombocytopenia (up to 36%), neutropenia (up to 34%), anemia (up to 27%)Common (1% to 10%): Decreased white blood cell countUncommon (0.1% to 1%): Decreased platelet count[Ref]
Very common (10% or more): Decreased weight (up to 48%), increased glucose (up to 45%), decreased appetite (up to 40%), increased albumin (up to 34%), decreased albumin (up to 34%), decreased phosphorus (up to 34%), decreased calcium (up to 33%), decreased sodium (up to 31%), increased potassium (up to 27%), decreased magnesium (up to 26%), anorexia (up to 22%), decreased glucose (up to 17%)Common (1% to 10%): Increased lipase, increased amylase, dehydration, abnormal blood cholesterol[Ref]
Very common (10% or more): Musculoskeletal pain (up to 23%), myalgia (up to 23%), asthenia (up to 14%)Common (1% to 10%): Arthralgia, muscle spasms[Ref]
Common (1% to 10%): Blurred visionUncommon (0.1% to 1%): Eyelash discoloration
Frequency not reported: Increased toxicity and mortality with other cancer therapies
-Fatal toxicities including pulmonary hemorrhage, gastrointestinal hemorrhage, and sudden death have occurred when used with other cancer agents.
Very common (10% or more): Dyspnea (up to 20%), cough (up to 17%)Common (1% to 10%): PneumothoraxUncommon (0.1% to 1%): Rhinorrhea[Ref]
1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0
2. Cerner Multum,  Inc. "Australian Product Information." O 0
3. "Product Information. Votrient (pazopanib)." GlaxoSmithKline, Research Triangle Park, NC. 
It is possible that some side effects of Votrient may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.

Abdominal or stomach pain or tenderness
black, tarry stools
bleeding gums
blood in the urine or stools
blurred vision
chest pain
chills
clay colored stools
cloudy urine
constipation
cough
coughing up blood
dark urine
decreased appetite
depressed mood
difficulty with breathing or swallowing
dizziness
dry skin and hair
feeling cold
fever
hair loss
headache
hoarseness or husky voice
increased menstrual flow or vaginal bleeding
itching or skin rash
loss of appetite
lower back or side pain
muscle cramps and stiffness
nausea and vomiting
nervousness
nosebleeds
painful or difficult urination
pale skin
paralysis
pinpoint red spots on the skin
pounding in the ears
prolonged bleeding from cuts
red or black, tarry stools
red or dark brown urine
redness, swelling, or pain of the skin
scaling of the skin on the hands and feet
slow or fast heartbeat
sore throat
sores, ulcers, or white spots on the lips or in the mouth
swelling of the feet or lower legs
swollen glands
tingling of the hands and feet
ulceration of the skin
unusual bleeding or bruising
unusual tiredness or weakness
weight gain
yellow eyes or skin


Bleeding from rectum or bloody stools
bloody nose
chest discomfort
confusion
fainting
irregular or slow heart rate
numbness or tingling in the face, arms, or legs
pain or discomfort in the shoulders, arms, jaw, back, or neck
sweating
swelling or puffiness of the face
trouble speaking, thinking, or walking


Change in hair color
change in taste
decreased weight
diarrhea
hair loss
lack or loss of strength
loss of taste
thinning of the hair
weight loss


Acid or sour stomach
belching
heartburn
indigestion
stomach discomfort, upset, or pain

